Stevanato Group Future Growth
Future criteria checks 2/6
Stevanato Group is forecast to grow earnings and revenue by 19.8% and 8.5% per annum respectively. EPS is expected to grow by 19.1% per annum. Return on equity is forecast to be 12.8% in 3 years.
Key information
19.8%
Earnings growth rate
19.11%
EPS growth rate
| Life Sciences earnings growth | 17.2% |
| Revenue growth rate | 8.5% |
| Future return on equity | 12.78% |
| Analyst coverage | Good |
| Last updated | 03 Jan 2026 |
Recent future growth updates
Recent updates
Stevanato: Structural Growth Intact, Buy Confirmed
Jan 03Investors Interested In Stevanato Group S.p.A.'s (NYSE:STVN) Earnings
Sep 22
Here's What Analysts Are Forecasting For Stevanato Group S.p.A. (NYSE:STVN) After Its Second-Quarter Results
Aug 08Stevanato Group (NYSE:STVN) Takes On Some Risk With Its Use Of Debt
Jun 23A Look At The Intrinsic Value Of Stevanato Group S.p.A. (NYSE:STVN)
May 19Shareholders Should Be Pleased With Stevanato Group S.p.A.'s (NYSE:STVN) Price
Mar 26Stevanato: Ramping Syringe Demand, Buy Confirmed
Mar 09Is Stevanato Group (NYSE:STVN) A Risky Investment?
Feb 27Calculating The Fair Value Of Stevanato Group S.p.A. (NYSE:STVN)
Feb 01
Engineering Optimization And Capacity Expansion To Unlock Growth Opportunities
Optimizing the Engineering segment and strategic shifts towards ready-to-use systems are expected to drive cost savings, improve margins, and boost productivity.Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement
Nov 13Stevanato: Destock Pressures, Long-Term Upside
May 29Stevanato: Destocking And Valuation Risk (Rating Downgrade)
Mar 12Stevanato: Guidance Reiterated And Supportive Revenue Growth
Nov 22Stevanato: Secular Tailwinds In Biologics Support Downstream Demand
Sep 15Stevanato Group: Undeniable Quality, But Lacking Upside
Jun 14Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2028 | 1,569 | 268 | 198 | N/A | 2 |
| 12/31/2027 | 1,416 | 217 | 133 | N/A | 8 |
| 12/31/2026 | 1,285 | 171 | 30 | 236 | 11 |
| 12/31/2025 | 1,174 | 137 | -14 | 233 | 11 |
| 9/30/2025 | 1,170 | 141 | -36 | 236 | N/A |
| 6/30/2025 | 1,145 | 135 | -64 | 207 | N/A |
| 3/31/2025 | 1,125 | 125 | -99 | 184 | N/A |
| 12/31/2024 | 1,104 | 118 | -158 | 156 | N/A |
| 9/30/2024 | 1,094 | 115 | -187 | 122 | N/A |
| 6/30/2024 | 1,088 | 123 | -257 | 138 | N/A |
| 3/31/2024 | 1,083 | 136 | -276 | 140 | N/A |
| 12/31/2023 | 1,085 | 146 | -337 | 105 | N/A |
| 9/30/2023 | 1,057 | 149 | -268 | 155 | N/A |
| 6/30/2023 | 1,031 | 147 | -216 | 117 | N/A |
| 3/31/2023 | 1,010 | 143 | -182 | 135 | N/A |
| 12/31/2022 | 984 | 143 | -140 | 103 | N/A |
| 9/30/2022 | 924 | 139 | -114 | 99 | N/A |
| 6/30/2022 | 893 | 122 | -78 | 121 | N/A |
| 3/31/2022 | 863 | 125 | -13 | 133 | N/A |
| 12/31/2021 | 844 | 134 | 20 | 133 | N/A |
| 9/30/2021 | 818 | 123 | 32 | 139 | N/A |
| 6/30/2021 | 761 | 121 | 72 | 171 | N/A |
| 3/31/2021 | 718 | 108 | 77 | 171 | N/A |
| 12/31/2020 | 662 | 79 | 60 | 156 | N/A |
| 12/31/2019 | 537 | 39 | -31 | 43 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: STVN's forecast earnings growth (19.8% per year) is above the savings rate (3.3%).
Earnings vs Market: STVN's earnings (19.8% per year) are forecast to grow faster than the US market (15.9% per year).
High Growth Earnings: STVN's earnings are forecast to grow, but not significantly.
Revenue vs Market: STVN's revenue (8.5% per year) is forecast to grow slower than the US market (10.4% per year).
High Growth Revenue: STVN's revenue (8.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: STVN's Return on Equity is forecast to be low in 3 years time (12.8%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/04 02:29 |
| End of Day Share Price | 2026/01/02 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Stevanato Group S.p.A. is covered by 18 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Curtis Moiles | BNP Paribas |
| Hugo Solvet | BNP Paribas |
| Michael Ryskin | BofA Global Research |